These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 2834257)

  • 41. The role of opiate receptors and cholinergic neurons in the gastrocolonic response.
    Sun EA; Snape WJ; Cohen S; Renny A
    Gastroenterology; 1982 Apr; 82(4):689-93. PubMed ID: 6277721
    [TBL] [Abstract][Full Text] [Related]  

  • 42. How many segments are necessary to characterize delayed colonic transit time?
    Bouchoucha M; Devroede G; Bon C; Raynaud JJ; Bejou B; Benamouzig R
    Int J Colorectal Dis; 2015 Oct; 30(10):1381-9. PubMed ID: 26062871
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Scintigraphic evaluation of colonic motility in patients with anorectal malformations and constipation.
    Zuccarello B; Romeo C; Scalfari G; Impellizzeri P; Montalto AS; D'Oppido D; Campennì A; Formica I; Baldari S
    J Pediatr Surg; 2006 Feb; 41(2):310-3. PubMed ID: 16481241
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of naloxone on feedback regulation of small bowel transit by fat.
    Kinsman RI; Read NW
    Gastroenterology; 1984 Aug; 87(2):335-7. PubMed ID: 6735077
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacological actions of a novel mixed opiate agonist/antagonist: naloxone benzoylhydrazone.
    Gistrak MA; Paul D; Hahn EF; Pasternak GW
    J Pharmacol Exp Ther; 1989 Nov; 251(2):469-76. PubMed ID: 2553921
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of verapamil on human intestinal transit.
    Krevsky B; Maurer AH; Niewiarowski T; Cohen S
    Dig Dis Sci; 1992 Jun; 37(6):919-24. PubMed ID: 1587197
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differential blockade by naloxonazine of two mu opiate actions: analgesia and inhibition of gastrointestinal transit.
    Paul D; Pasternak GW
    Eur J Pharmacol; 1988 May; 149(3):403-4. PubMed ID: 2842168
    [No Abstract]   [Full Text] [Related]  

  • 48. Faecal retention: a common cause in functional bowel disorders, appendicitis and haemorrhoids--with medical and surgical therapy.
    Raahave D
    Dan Med J; 2015 Mar; 62(3):. PubMed ID: 25748875
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of A3309, an ileal bile acid transporter inhibitor, on colonic transit and symptoms in females with functional constipation.
    Wong BS; Camilleri M; McKinzie S; Burton D; Graffner H; Zinsmeister AR
    Am J Gastroenterol; 2011 Dec; 106(12):2154-64. PubMed ID: 21876564
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Motility and tone of the left colon in constipation: a role in clinical practice?
    O'Brien MD; Camilleri M; von der Ohe MR; Phillips SF; Pemberton JH; Prather CM; Wiste JA; Hanson RB
    Am J Gastroenterol; 1996 Dec; 91(12):2532-8. PubMed ID: 8946981
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ambulatory assessment of colonic motility using the electromagnetic capsule tracking system: Effect of opioids.
    Mark EB; Klinge MW; Grønlund D; Poulsen JL; Schlageter V; Scott SM; Krogh K; Drewes AM
    Neurogastroenterol Motil; 2020 Mar; 32(3):e13753. PubMed ID: 31721398
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Blockade by naloxone and naltrexone of the TRH-induced stimulation of colonic transit in the rabbit.
    Horita A; Carino MA; Pae YS
    Eur J Pharmacol; 1985 Feb; 108(3):289-93. PubMed ID: 3921389
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Oral naloxone antagonizes loperamide-induced delay of orocecal transit.
    Basilisco G; Camboni G; Bozzani A; Paravicini M; Bianchi PA
    Dig Dis Sci; 1987 Aug; 32(8):829-32. PubMed ID: 3608730
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tegaserod accelerates orocecal transit in patients with constipation-predominant irritable bowel syndrome.
    Prather CM; Camilleri M; Zinsmeister AR; McKinzie S; Thomforde G
    Gastroenterology; 2000 Mar; 118(3):463-8. PubMed ID: 10702196
    [TBL] [Abstract][Full Text] [Related]  

  • 55. GR 38032F (ondansetron), a selective 5HT3 receptor antagonist, slows colonic transit in healthy man.
    Talley NJ; Phillips SF; Haddad A; Miller LJ; Twomey C; Zinsmeister AR; MacCarty RL; Ciociola A
    Dig Dis Sci; 1990 Apr; 35(4):477-80. PubMed ID: 2138532
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antidiarrheal properties of supraspinal mu and delta and peripheral mu, delta and kappa opioid receptors: inhibition of diarrhea without constipation.
    Shook JE; Lemcke PK; Gehrig CA; Hruby VJ; Burks TF
    J Pharmacol Exp Ther; 1989 Apr; 249(1):83-90. PubMed ID: 2540324
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Morphine no longer blocks gastrointestinal transit but retains antinociceptive action in diallylnormorphine-pretreated rats.
    Tavani A; Bianchi G; Manara L
    Eur J Pharmacol; 1979 Oct; 59(1-2):151-4. PubMed ID: 510395
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Enkephalins, other endogenous opioids and colonic motility in dog and man.
    Buéno L; Fioramonti J
    Gastroenterol Clin Biol; 1987; 11(3 Pt 2):69B-76B. PubMed ID: 3038653
    [No Abstract]   [Full Text] [Related]  

  • 59. Oral naloxone reduces constipation but not antinociception from oral morphine in the rat.
    Jurna I; Kaiser R; Kretz O; Baldauf J
    Neurosci Lett; 1992 Aug; 142(1):62-4. PubMed ID: 1407720
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Differentiation of prolonged colonic transit using scintigraphy with indium-111-labeled polystyrene pellets.
    Eising EG; von der Ohe MR
    J Nucl Med; 1998 Jun; 39(6):1062-6. PubMed ID: 9627344
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.